Výsledky vyhledávání - "Rustem F. Khamitov"

Akademický článek

Non-specific prevention of COVID-19 during vaccination against a new coronavirus infection: results of a multicenter, double-blind, placebo-controlled, randomized clinical trial

Autor: Marina G. Avdeeva, Oksana N. Belousova, Ekaterina A. Orlova, Rustem F. Khamitov, Yury G. Shvarts, Irina E. Kravchenko

Publikováno v: Терапевтический архив, Vol 94, Iss 11, Pp 1268-1277 (2022)

Background. A multicenter, double-blind, placebo-controlled, randomized clinical trial (RCT) of the phase III efficacy and safety of Ergoferon for the non-specific prevention of COVID-19 during vaccination against a new coronavirus infection was cond

Externí odkaz: https://doaj.org/article/639462bd110e46d9b97cb429ec4b9b5f

Zobrazit plný text záznamu

Akademický článek

Fibrous lung tissue lesions: treatment opportunities for post-COVID-19 patients

Autor: Aleksandr V. Zhestkov, Rustem F. Khamitov, Aleksandr A. Vizel, Maksim O. Zolotov

Publikováno v: Наука и инновации в медицине, Vol 7, Iss 2, Pp 81-84 (2022)

The article presents the analysis of scientific databases eLIBRARY, PubMed, Scopus on the topic of COVID-19 adverse outcomes and the treatment methods for their prevention. The post-COVID-19 syndrome is a pathological condition that includes persi

Externí odkaz: https://doaj.org/article/f00c11570aa1470c82bcf1aed87e6ddb

Zobrazit plný text záznamu

Akademický článek

Evaluation of the efficacy and safety of a complex antiviral drug based on antibodies in the treatment of adult patients with acute respiratory viral infection

Autor: Rustem F. Khamitov, Vladimir V. Nikiforov, Andrey A. Zaytsev, Irina N. Tragira

Publikováno v: Терапевтический архив, Vol 94, Iss 1, Pp 83-93 (2022)

Aim. To evaluate the efficacy and safety of Raphamin, containing technologically processed affinity-purified antibodies to interferon , CD4 receptor, 1 domain of the major histocompatibility complex class II and 2 microglobulin major histocompatibili

Externí odkaz: https://doaj.org/article/75ed506b031040d2b63da7389d552cb3

Zobrazit plný text záznamu

COVID-19 OUTCOMES: DRUG TREATMENT OPTIONS

Autor: Alexander A. Vizel, Vasily D. Fedotov, Rustem F. Khamitov, Alexander V. Zhestkov

Publikováno v: The Bulletin of Contemporary Clinical Medicine. 14:104-111

Background. Since December 2019 there has been a rapid spread of the COVID-19 pandemic across most of the world. This has determined the enormous burden on the global economy. The burden of the new coronavirus infection is determined not only by the

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::09201a2a1598bb697a21a238b185fdee
https://doi.org/10.20969/vskm.2021.14(5).104-111

Zobrazit plný text záznamu

THROMBOСYTOPENIA AND OTHER MANIFESTATIONS OF СOAGULOPATHY: DIAGNOSTIС AND TREATMENT OPTIONS FOR СOVID-19 NEW СORONAVIRUS INFEСTION

Autor: Alsu F. Molostvova, Rustem F. Khamitov, Liliya M. Salimova

Publikováno v: The Bulletin of Contemporary Clinical Medicine. 14:76-83

An important role in the development of adverse outcomes of new coronavirus infection (COVID-19) is played by hemostasis disorders, one manifestation of which is thrombocytopenia. Often it is difficult for the clinician to identify the underlying cau

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::0463e9a188701a6c10590492cf98d283
https://doi.org/10.20969/vskm.2021.14(3).76-83

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání